Vasoreactive effects of hypothalamic sodium transport inhibitor.
Mir
M A
MA
Department of Medicine, University of Wales College of Medicine, Heath Park, Cardiff, UK.
Morgan
K
K
Chappell
S
S
Lewis
M
M
Spurlock
G
G
Collins
P
P
Lewis
M
M
D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects; D002118:Calcium / Q000378:metabolism; D007031:Hypothalamus / Q000378:metabolism*; D066298:In Vitro Techniques; D010455:Peptides / Q000302:isolation & purification / Q000378:metabolism / Q000494:pharmacology*; D010477:Perfusion; D011817:Rabbits; D051381:Rats; D012964:Sodium / Q000378:metabolism*; D014662:Vasoconstrictor Agents
D010455:Peptides; D014662:Vasoconstrictor Agents; C029311:serum sodium transport inhibitor; D012964:Sodium; D002118:Calcium